SPOTLIGHT -
Slideshow
Author(s):
Which of these agents best prevents relapse? A recent study employed a novel approach to find out.
April in Review: Updates on the Psychiatric Treatment Pipeline
Here's to a Psychedelic Revolution
Cobenfy as Add-On Treatment for Schizophrenia Fails to Meet Primary Endpoint in Phase 3 ARISE Trial
Treating ‘Morally Objectionable’ Patients
Treating Schizophrenia: Bringing Together Pharmacists and Clinicians for Patient Care
The Slow Road to Psychosis